Moonlight AI Raises €2.8M Seed
Moonlight AI raises €2.8 million Seed round co-led by Lotus One Investment, VP Venture Partners, and MEDIN Fund to expand its AI-driven diagnostic software for
Moonlight AI Raises €2.8M Seed
Moonlight AI, a Swiss startup, specializes in AI-driven diagnostics, building image analysis software for clinical-grade diagnostics to turn routine blood and cytology imaging into genomic insights. The company has successfully closed a €2.8 million Seed funding round.
Investors
This Seed funding round was co-led by Lotus One Investment (Singapore), VP Venture Partners (Switzerland), and MEDIN Fund (Tunisia). Additional participation came from N&V Capital (Liechtenstein) and existing investor QAI Ventures (Switzerland).
Moonlight AI Use of Funds
The capital raised in this Seed round is primarily aimed at expanding Moonlight AI's proprietary data library, which is the first to connect whole slide imaging of cytopathology samples with high-quality genomic data. The company also plans to expand its team, further develop diagnostic solutions for conditions such as myelodysplastic syndrome (MDS), non-small cell lung cancer, and chronic lymphocytic leukaemia (CLL). Additionally, the funding will accelerate its path to commercialisation and regulatory approval.
About Moonlight AI
Founded in 2022, Moonlight AI was co-founded by Christian Ruiz (CEO), Nicole H. Romano (CTO), and Dr Stefan Habringer (Chief Medical Officer). The company's mission is to democratise access to genomic information for accurate cancer diagnostics. Moonlight AI converts medical images into actionable insights, empowering haematologists and pathologists to make faster, more accurate treatment decisions for cancer patients globally. Their AI-based diagnostics software integrates with diagnostic lab imaging hardware, using computer vision to detect genomic biomarkers and complex disease signatures directly from routine imaging of blood and cytology smears, complementing and triaging molecular testing.
Funding Details
Company: Moonlight AI
Raised: €2.8M
Round: Seed
Funding Date: May 6, 2026
Lead Investor: Lotus One Investment, VP Venture Partners, MEDIN Fund
Additional Investors: N&V Capital, QAI Ventures
Software Category: AI-driven diagnostics, Medical Imaging Software, HealthTech
Company Website: https://moonlight-ai.com
Source: https://bebeez.eu/2026/05/06/swiss-startup-moonlight-ai-raises-e2-8-million-to-turn-routine-blood-and-cytology-imaging-into-genomic-insights/